4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-019287
Senior Vice President and CFO gave up 6,996 shares (to pay taxes)
- Senior Vice President and CFO acquired 7,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-05-22 | Exercise or conversion : show line 1 in the form | +7,750 | $4.73 | $36,658 | 149,210 | D |
| 2017-05-22 | Shares withheld for taxes : show line 2 in the form | −6,996 | $5.24 | $36,659 | 142,214 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-05-22 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −7,750 | $4.73 | 2022-03-01 | 7,750 | 4,000 | D |
Loading xslF345X03/form4.xml…